Article Details

China's Asymchem Biotechnology to raise $392m from Hillhouse, others - DealStreetAsia

Retrieved on: 2022-03-28 06:16:28

Tags for this article:

Click the tags to see associated articles and topics

China's Asymchem Biotechnology to raise $392m from Hillhouse, others - DealStreetAsia. View article details on HISWAI: https://www.dealstreetasia.com/stories/hillhouse-aymchem-biotech-286321/

Excerpt

Shanghai Asymchem Biotechnology Development, a wholly-owned subsidiary of China-based drug developer Asymchem Laboratories (Tianjin), ...

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up